Pioglitazone
- Product NDC
- 60687-905
- 11-digit product format
- 606870905
- Labeler code
- 60687
- Product ID
- 60687-905_47cd336a-efb3-1f80-e063-6294a90abc1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA077210
- Marketing category
- ANDA
- Marketing start
- 2026-01-01
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| JQT35NPK6C | PIOGLITAZONE HYDROCHLORIDE | 112529-15-4 | PIOGLITAZONE HYDROCHLORIDE |
| X4OV71U42S | PIOGLITAZONE | 111025-46-8 | Pioglitazone |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 60687-905-21 | 60687090521 | 30 BLISTER PACK in 1 CARTON (60687-905-21) / 1 TABLET in 1 BLISTER PACK (60687-905-11) | 30 blister pack | 2026-01-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Pioglitazone | American Health Packaging | 2026-01-07 | HUMAN PRESCRIPTION DRUG LABEL | 6 |